,
your personalized virtual assistant to find clinical trials. Go head, 
Robin Joyce, MD
Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 7
- CONDITIONS18
- INTERVENTIONS11
- SINCE2004
Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
March 2010 - February 2014
Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
April 2008 - January 2011
Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
June 2008 - June 2011
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
October 2004 - June 2011
Bortezomib Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
August 2006 - August 2010
Bortezomib Plus Rituximab for Initial Therapy of EBV+ PTLD
July 2010 - February 2012
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Virus Diseases
Carcinoma, Renal Cell
Kidney Neoplasms
Hodgkin Disease
Lymphoproliferative Disorders
Epstein-Barr Virus Infections
Rituximab
Lenalidomide
Bortezomib
Dexamethasone
Clofarabine
Antithymocyte Globulin
Pyrimethamine
Hcd122
Dendritic Cell Tumor Fusion Vaccine
Granulocyte Macrophage Colony Stimulating Factor (Gm-Csf)
Dendritic Cell Tumor Fusion
